Hua Medicine's IPO

Hua Medicine raised a round of funding on September 14, 2018. Investors include Public.

Hua Medicine (华领医药) (HK: 02552) is a clinical-stage drug development company in China, focusing on therapies for the treatment of diabetes and CNS disorders.…

Articles about Hua Medicine's IPO: